Cargando…

Intratumoral localization and activity of 17β-hydroxysteroid dehydrogenase type 1 in non-small cell lung cancer: a potent prognostic factor

BACKGROUND: Estrogens were recently demonstrated to be synthesized in non-small cell lung carcinomas (NSCLCs) via aromatase activity and aromatase inhibitor (AI) did suppressed estrogen receptor (ER) positive NSCLC growth. However, other enzymes involved in intratumoral production and metabolism of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verma, Mohit K, Miki, Yasuhiro, Abe, Keiko, Suzuki, Takashi, Niikawa, Hiromichi, Suzuki, Satoshi, Kondo, Takashi, Sasano, Hironobu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3724709/ https://www.ncbi.nlm.nih.gov/pubmed/23837683 http://dx.doi.org/10.1186/1479-5876-11-167

Ejemplares similares

17β-Hydroxysteroid Dehydrogenase Type 2 Expression Is Induced by Androgen Signaling in Endometrial Cancer
por: Hashimoto, Chiaki, et al.
Publicado: (2018)

11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma
por: Saito, Ryoko, et al.
Publicado: (2020)

GATA4 immunolocalization in breast carcinoma as a potent prognostic predictor
por: Takagi, Kiyoshi, et al.
Publicado: (2014)

17 β -Hydroxysteroid dehydrogenase type 1 and type 2 in human breast carcinoma: a correlation to clinicopathological parameters
por: Suzuki, T, et al.
Publicado: (2000)

ARHGAP15 in Human Breast Carcinoma: A Potent Tumor Suppressor Regulated by Androgens
por: Takagi, Kiyoshi, et al.
Publicado: (2018)

Substituted Aryl Benzylamines as Potent and Selective Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 3
por: Vicker, Nigel, et al.
Publicado: (2021)

Forkhead Box I1 in Breast Carcinoma as a Potent Prognostic Factor
por: Onodera, Yoshiaki, et al.
Publicado: (2021)

Abnormal expression of miR‐1 in breast carcinoma as a potent prognostic factor
por: Minemura, Hiroyuki, et al.
Publicado: (2015)

TACC2 (transforming acidic coiled‐coil protein 2) in breast carcinoma as a potent prognostic predictor associated with cell proliferation
por: Onodera, Yoshiaki, et al.
Publicado: (2016)

CITED2 in breast carcinoma as a potent prognostic predictor associated with proliferation, migration and chemoresistance
por: Minemura, Hiroyuki, et al.
Publicado: (2016)

Intratumoral androgen metabolism and actions in invasive lobular carcinoma of the breast
por: Yoda, Tomomi, et al.
Publicado: (2014)

Visualization of the protein–protein interactions of hormone receptors in hormone-dependent cancer research
por: Iwabuchi, Erina, et al.
Publicado: (2022)

Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer
por: Hilborn, Erik, et al.
Publicado: (2017)

An inhibition of p62/SQSTM1 caused autophagic cell death of several human carcinoma cells
por: Nihira, Kaito, et al.
Publicado: (2014)

Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer
por: Ganguly, Shinjini, et al.
Publicado: (2023)

Human 3β‐hydroxysteroid dehydrogenase type 1 in human breast cancer: clinical significance and prognostic associations
por: Hanamura, Toru, et al.
Publicado: (2016)

Glioblastoma cells express crucial enzymes involved in androgen synthesis: 3β‐hydroxysteroid dehydrogenase, 17‐20α‐hydroxylase, 17β‐hydroxysteroid dehydrogenase and 5α‐reductase
por: Mondragón, Jose Antonio, et al.
Publicado: (2021)

ODP559 The prognostic role of IL-17A-neutrophils crosstalk in triple-negative breast cancer
por: Khalid, Freeha, et al.
Publicado: (2022)

Immunolocalization of Corticotropin-Releasing Hormone (CRH) and Its Receptors (CRHR1 and CRHR2) in Human Endometrial Carcinoma: CRHR1 as a Potent Prognostic Factor
por: Sato, Naoko, et al.
Publicado: (2014)

Interference of Paraben Compounds with Estrogen Metabolism by Inhibition of 17β-Hydroxysteroid Dehydrogenases
por: Engeli, Roger T., et al.
Publicado: (2017)

Structural basis of lipid-droplet localization of 17-beta-hydroxysteroid dehydrogenase 13
por: Liu, Shenping, et al.
Publicado: (2023)

Dendriform pulmonary ossification: unusual cause of spontaneous pneumothorax
por: Abe, Jiro, et al.
Publicado: (2014)

Discovery of Adamantyl Heterocyclic Ketones as Potent 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
por: Su, Xiangdong, et al.
Publicado: (2011)

Adamantyl carboxamides and acetamides as potent human 11β-hydroxysteroid dehydrogenase type 1 inhibitors
por: Su, Xiangdong, et al.
Publicado: (2012)

Heterogeneous Nuclear Ribonucleoprotein K Is Involved in the Estrogen-Signaling Pathway in Breast Cancer
por: Iwabuchi, Erina, et al.
Publicado: (2021)

Microtubule-Associated Protein 2 as a DHEA Binding Protein in Endometrial Cancer
por: Miki, Yasuhiro, et al.
Publicado: (2021)

Characterization of 17α-hydroxysteroid dehydrogenase activity (17α-HSD) and its involvement in the biosynthesis of epitestosterone
por: Bellemare, Véronique, et al.
Publicado: (2005)

Dimerization and enzymatic activity of fungal 17β-hydroxysteroid dehydrogenase from the short-chain dehydrogenase/reductase superfamily
por: Kristan, Katja, et al.
Publicado: (2005)

OLFM4, LY6D and S100A7 as potent markers for distant metastasis in estrogen receptor‐positive breast carcinoma
por: Mayama, Akifumi, et al.
Publicado: (2018)

Expression and localization of estrogenic type 12 17β-hydroxysteroid dehydrogenase in the cynomolgus monkey
por: Liu, Hong, et al.
Publicado: (2007)

Interactions of 17β-Hydroxysteroid Dehydrogenase Type 10 and Cyclophilin D in Alzheimer's Disease
por: Kristofikova, Zdenka, et al.
Publicado: (2020)

17β-Hydroxysteroid dehydrogenases involved in local oestrogen synthesis have prognostic significance in breast cancer
por: Gunnarsson, C, et al.
Publicado: (2005)

Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma
por: Wu, Min, et al.
Publicado: (2021)

Steroid sulphatase and oestrogen sulphotransferase in human non-small-cell lung carcinoma
por: Iida, S, et al.
Publicado: (2013)

Epitope Characterization of an Aromatase Monoclonal Antibody Suitable for the Assessment of Intratumoral Aromatase Activity
por: Hong, Yanyan, et al.
Publicado: (2009)

Hydroxybenzothiazoles as New Nonsteroidal Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1 (17β-HSD1)
por: Spadaro, Alessandro, et al.
Publicado: (2012)

11β-Hydroxysteroid Dehydrogenase 2 in Preeclampsia
por: Kosicka, Katarzyna, et al.
Publicado: (2016)

Microbial Hydroxysteroid Dehydrogenases: From Alpha to Omega
por: Doden, Heidi L., et al.
Publicado: (2021)

SUN-159 17-beta Hydroxysteroid Dehydrogenase 3 Deficiency in 1 Month Old Infant
por: Mathew, Deepa, et al.
Publicado: (2020)

Roles of Aryl Hydrocarbon Receptor in Aromatase-Dependent Cell Proliferation in Human Osteoblasts
por: Miki, Yasuhiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_lk6sbodsff8h1l1peh00pm5g8e